Dr. Nabila Nora Bennani is an Assistant Professor of Medicine at the Mayo Clinic. The clinical focus of her is on treating lymphomas, while her particular research focus is on T-cell lymphomas. Dr. Bennani's goal is to develop early-phase novel clinical trials with the aim of uncovering novel therapies and improving outcomes for patients. She serves as a principal investigator, co-principal investigator, and co-investigator in several ongoing and in-development clinical trials. She is also among select faculty members who provide chimeric antigen receptor T-cell therapy (CAR T-cell therapy) for relapsed lymphomas.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)